SCHEMBL332348

SCHEMBL332348

c1ccc(N(c2ccccc2)c2cc(N(c3ccccc3)c3ccccc3)cc(N(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
L3MBTL1 Q9Y468 3/20 0.57
TDP1 Q9NUW8 2/20 0.57
MAPT P10636 2/20 0.57
KDM4E B2RXH2 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
CRHBP P24387 1/20 0.46
ATM Q13315 1/20 0.46
CRHR2 Q13324 1/20 0.46
TLR9 Q9NR96 1/20 0.46
NPSR1 Q6W5P4 1/20 0.39
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.38
TSHR P16473 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15595125 1.00 ALDH1A1 (0.57) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL261694 0.97 ALDH1A1 (0.62) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL15595167 0.97 ALDH1A1 (0.62) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL24119809 0.94 ALDH1A1 (0.52) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL22336468 0.94 ALDH1A1 (0.52) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL21468608 0.94 ALDH1A1 (0.52) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL15595154 0.94 ALDH1A1 (0.52) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL28163442 0.93 ALDH1A1 (0.63) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL13608528 0.91 ALDH1A1 (0.50) ALDH1A1L3MBTL1TDP1MAPTKDM4E
SCHEMBL12936130 0.90 ALDH1A1 (0.55) ALDH1A1L3MBTL1TDP1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12581795-B2 Display device and method for manufacturing same SHARP KABUSHIKI KAISHA (JP) 2026-03-17 US claimed
US-12495665-B2 Display device having carrier blocking section between pixels SHARP KABUSHIKI KAISHA (JP) 2025-12-09 US claimed
CN-120082898-A Method for synthesizing electrocatalytic ketone compound 西华师范大学 2025-06-03 CN claimed
US-20230389392-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME SHARP KABUSHIKI KAISHA (JP) 2023-11-30 US claimed
US-20230309334-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME SHARP KABUSHIKI KAISHA (JP) 2023-09-28 US claimed
WO-2022085097-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME シャープ株式会社 2022-04-28 WO claimed
WO-2022038694-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME シャープ株式会社 2022-02-24 WO claimed
US-20210288256-A1 OLED DEVICE STRUCTURE, OLED DISPLAY PANEL AND DISPLAY DEVICE XIANYANG CAIHONG OPTOELECTRONICS TECHNOLOGY CO.,LTD (CN) 2021-09-16 US claimed
CN-112500563-A Synthesis method of three-dimensional conjugated conductive polyaniline and application of three-dimensional conjugated conductive polyaniline as lithium ion battery cathode binder 四川普利司德高分子新材料有限公司 2021-03-16 CN claimed
US-10396449-B2 Photovoltaic element with an included resonator VYSOKE UCENI TECHNICKE V BRNE (CZ) 2019-08-27 US claimed
US-20170125624-A1 Photovoltaic Element with an included Resonator VYSOKE UCENI TECHNICKE V BRNE (CZ) 2017-05-04 US claimed
CN-106226378-A A kind of nitrogen dioxide sensor being embedded with fluoropolymer and preparation method thereof 电子科技大学 2016-12-14 CN claimed
CN-102217110-B Derivatized fullerene-based dopants for organic semiconductors TECHNION RES & DEV FOUNDATION 2014-06-04 CN claimed
CN-101573324-B Arylamine compounds and electronic devices AGENCY SCIENCE TECH & RES 2013-11-20 CN claimed
US-8518559-B2 Arylamine compounds and electronic devices AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-08-27 US claimed
EP-2335299-A1 DERIVATIZED FULLERENE-BASED DOPANTS FOR ORGANIC SEMICONDUCTORS Technion Research and Development Foundation, Ltd. (IL) 2011-06-22 EP claimed
US-20100133519-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES AGENCY FOR SCIENCE, TECHNOLOGY ANR RESEARCH 2010-06-03 US claimed
WO-2010029542-A1 DERIVATIZED FULLERENE-BASED DOPANTS FOR ORGANIC SEMICONDUCTORS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) 2010-03-18 WO claimed
EP-2121573-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES Agency for Science Technology and Research (SG) 2009-11-25 EP claimed
WO-2008069756-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2008-06-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133519-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES TYR, AHR, ARNT ALDH1A1 868/4885L3MBTL1 1752/4885TDP1 3207/4885
US-12581795-B2 Display device and method for manufacturing same EPHA4, NECTIN4, L1CAM ALDH1A1 758/4885L3MBTL1 362/4885TDP1 2783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.